1. Home
  2. ZVRA vs IAUX Comparison

ZVRA vs IAUX Comparison

Compare ZVRA & IAUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • IAUX
  • Stock Information
  • Founded
  • ZVRA 2006
  • IAUX 2020
  • Country
  • ZVRA United States
  • IAUX United States
  • Employees
  • ZVRA N/A
  • IAUX N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • IAUX
  • Sector
  • ZVRA Health Care
  • IAUX
  • Exchange
  • ZVRA Nasdaq
  • IAUX Nasdaq
  • Market Cap
  • ZVRA 481.7M
  • IAUX 507.4M
  • IPO Year
  • ZVRA 2015
  • IAUX N/A
  • Fundamental
  • Price
  • ZVRA $11.05
  • IAUX $0.59
  • Analyst Decision
  • ZVRA Strong Buy
  • IAUX Buy
  • Analyst Count
  • ZVRA 9
  • IAUX 1
  • Target Price
  • ZVRA $23.25
  • IAUX $1.50
  • AVG Volume (30 Days)
  • ZVRA 1.2M
  • IAUX 3.5M
  • Earning Date
  • ZVRA 08-12-2025
  • IAUX 08-11-2025
  • Dividend Yield
  • ZVRA N/A
  • IAUX N/A
  • EPS Growth
  • ZVRA N/A
  • IAUX N/A
  • EPS
  • ZVRA N/A
  • IAUX N/A
  • Revenue
  • ZVRA $40,588,000.00
  • IAUX $55,970,000.00
  • Revenue This Year
  • ZVRA $303.00
  • IAUX $73.07
  • Revenue Next Year
  • ZVRA $77.66
  • IAUX $101.03
  • P/E Ratio
  • ZVRA N/A
  • IAUX N/A
  • Revenue Growth
  • ZVRA 46.47
  • IAUX N/A
  • 52 Week Low
  • ZVRA $6.19
  • IAUX $0.34
  • 52 Week High
  • ZVRA $13.16
  • IAUX $1.26
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 50.02
  • IAUX 38.91
  • Support Level
  • ZVRA $10.69
  • IAUX $0.55
  • Resistance Level
  • ZVRA $11.37
  • IAUX $0.68
  • Average True Range (ATR)
  • ZVRA 0.49
  • IAUX 0.03
  • MACD
  • ZVRA -0.21
  • IAUX -0.01
  • Stochastic Oscillator
  • ZVRA 12.50
  • IAUX 10.62

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About IAUX i-80 Gold Corp.

i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.

Share on Social Networks: